Facilitating Decentralised Clinical Trials in the EU

gru 19, 2022

The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have published recommendations that aim to facilitate the conduct of decentralised clinical trials (DCTs) while safeguarding the rights and well-being of participants as well as the robustness and reliability of the data collected.

Patrycja Buczak-Kula

Clinical Trials in the European Union (ACT EU).

https://www.ema.europa.eu/en/news/facilitating-decentralised-clinical-trials-eu

Axcellant is a global CRO, delivering meaningful value in the following areas

Can AI Write Radiology Reports? A Study Suggests It Can — and Save Time Doing It

A recent publication in npj Digital Medicine explored the use of AI-generated radiology reports — and the results are worth…

Exploring Partnerships and Clinical Innovation in New York

The Axcellant team recently traveled to New York to meet with research partners and clinical collaborators from across the U.S.…

Nuclear Medicine Procedures in Clinical Research: Safety, Standards, and Regulatory Oversight

What Are Nuclear Medicine Procedures and How Are They Used in Clinical Trials? Nuclear medicine procedures (NMPs) are diagnostic and/or…